Skip to main content
SpringerLink
Log in

Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The characteristics of 5-HT1A-recognition sites and receptor-mediated release of intracellular calcium were established in two transfected HeLa cell lines (HA 6 and HA 7) expressing different levels of human 5-HT1A receptors (about 3000 and 500 fmol/mg protein, Fargin et al. 1989; 1991; Raymond et al. 1989).

The pharmacological profiles of the binding (determined with [3H]8-OH-DPAT) and the calcium response (measured using Fura-2) were clearly of the 5-HT1A type. Compounds such as 5-HT, 5-CT and 8-OH-DPAT acted as full agonists on the calcium response in both HeLa cell lines. In addition, methiothepin, pindolol, NAN 190 and SDZ 216-525 (Seiler et al. 1991) acted as silent and potent antagonists.

Marked differences were observed in the responses mediated in the two cell lines. EC50 values of agonists (particularly 5-HT, 5-CT, flesinoxan and 8-OH-DPAT) were higher in HA 7 cells (up to 80-fold) than in other 5-HT1A receptor models (e.g. inhibition of adenylate cyclase in calf hippocampus). Further, a variety of compounds (ipsapirone, buspirone, spiroxatrine, MDL 73005) acted as agonists in HA 6 cells, whereas they behaved as silent antagonists in HA 7 cells (which express fewer receptors). By contrast, KB values for antagonists were comparable in HA 6 and HA 7 cells.

The present data show that EC50 values and intrinsic activity for a given drug are subject to large variations depending on the number of receptors expressed in the target tissue. The results obtained in HA 6 cells are comparable with respect to both potency and efficacy to those observed, in calf or mouse hippocampus (inhibition of forskolin stimulated adenylate cyclase), whereas the results obtained in HA 7 cells are similar to those reported in mouse cortex (which was suggested to represent an atypical subtype of the 5-HT1A receptor).

Since the agonist activity of a given compound at the same receptor can vary markedly, the present data show that intrinsic activity is not only ligand-dependent but also varies with the receptor-effector system studied. In addition, there seems to be no simple way to make predictions about intrinsic activity, since that feature is model-dependent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albert PR, Zhou Q-Y, Van Tol HHM, Bunzow JR, Civelli O (1990) Cloning functional expression and messenger RNA tissue distribution of the rat 5 hydroxytryptamine-1-A receptor gene. J Biol Chem 265:5825–5832

    Google Scholar 

  • Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B 220:141–162

    Google Scholar 

  • Black JW, Leff P, Shankley NP (1985) An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant. Br J Pharmacol 84:561–571

    Google Scholar 

  • Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN (1987) Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 335:588–592

    Google Scholar 

  • Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576

    Google Scholar 

  • Branchek TL, Weinshank RL, Macci MJ, Zgombick JM, Hartig PR (1991) Cloning and expression of a human 5-HT1D receptor. In: Fozard JR, Saxena PR (eds) Serotonin: molecular biology, receptors and functional effects. Birkhäuser, Basel, pp 21–32

    Google Scholar 

  • Capponi AM, Lew PD, Schlegel W, Pozzan T (1989) Use of intracellular calcium and membrane potential fluorescent indicators in neuroendocrine cells. In: Conn PM (ed) Neuroendocrine peptide methodology, selected methods in enzymology. Academic Press, New York, pp 315–340

    Google Scholar 

  • Cornfield LJ, Nelson DL, Taylor EW, Martin AR (1989) MDL 73005EF: Partial agonist at the 5-HT(1A) receptor negatively linked to adenylate cyclase. Eur J Pharmacol 173:189–192

    Google Scholar 

  • Dumuis A, Sebben M, Bockaert J (1988) Pharmacology of 5-hydroxytryptamine-lA-receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol Pharmacol 33:178–186

    Google Scholar 

  • Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988) The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335:358–360

    Google Scholar 

  • Fargin A, Raymond JR, Regan JW, Cotecchia S, Lefkowitz RJ, Caron MG (1989) Effector coupling mechanisms of the cloned 5-HT1A receptor. J Biol Chem 264:14848–14852

    Google Scholar 

  • Fargin A, Yamamoto K, Cotecchia S, Goldsmith PG, Spiegel AM, Lapetina EG, Caron MG, Lefkowitz RJ (1991) Dual coupling of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same G1 protein. Cell Signalling 3:547–551

    Google Scholar 

  • Fitzgerald L, Titeler M, Glennon RA, Yocca F (1989) Tritiated NAN-190 and tritiated BMY-7378: antagonist radioligand probes of the brain 5 HT-1A receptor. Neurosci Abstr 15:422

    Google Scholar 

  • Gartside SE, Cowen PJ, Hjorth S (1990) Effects of MDL 73005EF on central pre and postsynaptic 5-HT1A receptor function in the rat in vivo. Eur J Pharmacol 191:391–400

    Google Scholar 

  • Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of calcium indicators with improved fluorimetric properties. J Biol Chem 260:3440–3450

    CAS  PubMed  Google Scholar 

  • Herrick-Davis K, Titeler M (1988) Tritiated spiroxatrine a 5-HT-1A radioligand with agonist binding properties. J Neurochem 50:528–533

    Google Scholar 

  • Hibert M, Moser P (1990) MDL-72832 and MDL-73005EF novel potent and selective 5-HT-1A receptor ligands with different pharmacological properties. Drugs Future 15:159–170

    Google Scholar 

  • Hjorth, S, Sharp T (1990) Mixed agonist-antagonist properties of NAN-190 at 5-HT-1A receptors: behavioural and in-vivo brain microdialysis studies. Life Sci 46:955–963

    Google Scholar 

  • Hoyer D (1989) Biochemical mechanisms of 5-HT receptor-effector coupling in peripheral tissues. In: Fozard JR (ed) The peripheral actions of 5-hydroxytryptamine. Oxford University Press, Oxford, pp 72–99

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulgerine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Hoyer D, Neijt HC (1988) Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol Pharmacol 33:303–309

    Google Scholar 

  • Julius D, MacDermott AB, Axel R, Jessel TM (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558–564

    Google Scholar 

  • Kenakin TP, Morgan PH (1989) Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol Pharmacol 35: 214–222

    Google Scholar 

  • Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Leftkowitz RJ, Caron CG (1987) An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329:75–77

    Google Scholar 

  • Meller E, Goldstein M, Bohmaker K (1990) Receptor reserve for 5 hydroxytryptamine-1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5 hydroxytryptamine-1A agonists. Mol Pharmacol 37:231–237

    Google Scholar 

  • Middleton JP, Raymond JR, Whorton AR, Dennis VW (1990) Short-term regulation of Na+/K+ adenosine triphosphatase by recombinant serotonin 5-HT1A receptor expressed in HeLa cells. J Clin Invest 86:1799–1805

    Google Scholar 

  • Moser PC, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard JR (1990) Characterization of MDL-73005EF as a 5-HT-1A selective ligand and its effects in animal models of anxiety comparison with buspirone, 8-hydroxy-DPAT and diazepam. Br J Pharmacol 99:343–349

    Google Scholar 

  • Nelson DL, Monroe PJ, Yamamura HI (1987) [3H]spiroxatrine labels a serotonin-like site in the rat hippocampus. Life Sci 41: 1567–1576

    Google Scholar 

  • Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11:45–60

    Google Scholar 

  • Pritchett DB, Bach AWJ, Wozny M, Taleb O, Dal Toso R, Shih JC, Seeburg PH (1988) Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J 7:4135–4140

    Google Scholar 

  • Przegalinski E, Ismaiel AM, Chojnacka-Wojcik E, Budziszewska B, Tatarcynska D, Blaszcynska E (1990) The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(din-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Neuropharmacol 29:521–526

    Google Scholar 

  • Raymond JR (1991) Protein kinase C induces phosphorylation and desensitization of the human 5-HT1A receptor. J Biol Chem 266:14747–14753

    Google Scholar 

  • Raymond JR, Fargin A, Middleton JP, Graff JM, McNeill Haupt D, Caron MG, Lefkowitz RJ, Dennis VW (1989) The human 5-HT(1A) receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C. J Biol Chem 264:21943–21950

    Google Scholar 

  • Raymond JR, Albers FJ, Middleton JP, Lefkowitz RJ, Caron MG, Obeid LM, Dennis VW (1991) 5-HT1A and histamine H1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools. J Biol Chem 266:372–378

    Google Scholar 

  • Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA (1990) NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors. Brain Res 532: 191–196

    Google Scholar 

  • Schoeffter P, Hoyer D (1988) Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 95:975–985

    Google Scholar 

  • Schoeffter P, Hoyer D (1989a) Interactions of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B ligands exist? Naunyn-Schmiedeberg's Arch Pharmacol 339:675–683

    Google Scholar 

  • Schoeffter P, Hoyer D (1989b) How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:135–138

    Google Scholar 

  • Seiler MP, Stoll A, Hagenbach A, Floersheim P, Fozard JR, Kalkman HO, Mir AK, Siegl H, Schoeffter P, Hoyer D (1992) Novel approaches to drugs acting on “5-HT1 like” receptors. In: Sarel S, Mechoulam R, Agranat I (eds) Trends in medicinal chemistry “90”. Blackwell Scientific Publications (in press)

  • Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG (1990) Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. Eur J Pharmacol 176:331–340

    Google Scholar 

  • Yocca FD (1990) Neurochemistry and neurophysiology of buspirone and gepirone: Interactions at presynaptic and postsynaptic 5-HT1A receptors. J Clin Psychopharmacol 10:6S–12S

    Google Scholar 

  • Yocca FD, Hyslop DK, Smith DW, Maayani S (1987) BMY 7378, a buspirone analog with high affinity selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea-pig hippocampal membranes. Eur J Pharmacol 137:293–294

    Google Scholar 

  • Zemlan FP, Zieleniewski-Murphy A, Murphy RM, Behbehani MM (1990) BMY-7378 partial agonist at spinal cord 5-HT-1A receptors. Neurochem Int 16:515–522

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preclinical Research, 360/604, SANDOZ Pharma Ltd, CH-4002, Basel, Switzerland

    Hendrikus W. G. M. Boddeke, Philippe Schoeffter & Daniel Hoyer

  2. Department of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, 27710, Durham, NC, USA

    Annick Fargin & John R. Raymonde

  3. Department of Medicine (Nephrology Section), Department of Veteran Affairs Medical Center, 27705, Durham, NC, USA

    John R. Raymonde

Authors
  1. Hendrikus W. G. M. Boddeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annick Fargin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John R. Raymonde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philippe Schoeffter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Hoyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to D. Hoyer at the above address

J. R. Raymond was supported by the American Heart Association (Grant in Aid) and by a V. A. Merit Award

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boddeke, H.W.G.M., Fargin, A., Raymonde, J.R. et al. Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn-Schmiedeberg's Arch Pharmacol 345, 257–263 (1992). https://doi.org/10.1007/BF00168684

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00168684

Key words

Search

Navigation